http://pharmaexecnews.com Fri, 29 Apr 2011 14:00:12 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/ http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/#comments Fri, 01 Apr 2011 14:00:34 +0000 admin http://pharmaexecnews.com/?p=11406 http://pharmaexecnews.com/medical/healthcare-medical/arthritis-drug-combat-melanoma-skin-cancer/feed/ 0 http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/ http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/#comments Tue, 01 Mar 2011 14:00:17 +0000 admin http://pharmaexecnews.com/?p=11237 http://pharmaexecnews.com/biotechnology/zymes-receives-michael-fox-foundation-grant-pd-therapy-research/feed/ 0 http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/ http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/#comments Mon, 28 Feb 2011 14:00:33 +0000 admin http://pharmaexecnews.com/?p=11234 http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/feed/ 0 http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/ http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/#comments Fri, 25 Feb 2011 08:00:43 +0000 admin http://pharmaexecnews.com/?p=11197 http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/feed/ 0 http://pharmaexecnews.com/biotechnology/chimerix-funds-antiviral-drug-work-45m/ http://pharmaexecnews.com/biotechnology/chimerix-funds-antiviral-drug-work-45m/#comments Fri, 18 Feb 2011 08:00:15 +0000 admin http://pharmaexecnews.com/?p=11177 http://pharmaexecnews.com/biotechnology/chimerix-funds-antiviral-drug-work-45m/feed/ 0 http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/ http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/#comments Tue, 15 Feb 2011 08:00:31 +0000 admin http://pharmaexecnews.com/?p=11164 http://pharmaexecnews.com/biotechnology/diabetes-researcher-close-cure/feed/ 0 http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/ http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/#comments Thu, 10 Feb 2011 08:00:12 +0000 admin http://pharmaexecnews.com/?p=11150 http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/feed/ 0 http://pharmaexecnews.com/biotechnology/copying-biotech-medicine-attracts-drugmakers/ http://pharmaexecnews.com/biotechnology/copying-biotech-medicine-attracts-drugmakers/#comments Tue, 01 Feb 2011 08:00:05 +0000 admin http://pharmaexecnews.com/?p=11124 http://pharmaexecnews.com/biotechnology/copying-biotech-medicine-attracts-drugmakers/feed/ 0 http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/ http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/#comments Wed, 26 Jan 2011 08:00:17 +0000 admin http://pharmaexecnews.com/?p=11107 http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/feed/ 0 http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/ http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/#comments Mon, 10 Jan 2011 08:00:22 +0000 admin http://pharmaexecnews.com/?p=11057 http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/feed/ 0